Lung cancer highlights from ESMO 2022

ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc BrothersПодробнее

ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology BrothersПодробнее

ESMO 2023 highlights: advances in EGFR+ lung cancer second-line therapyПодробнее

8. ESMO 2022 HighlightsПодробнее

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2Подробнее

Highlights on adjuvant alectinib in early ALK positive NSCLC: The ALINA studyПодробнее

ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trialПодробнее

ESMO Sarcoma and Rare Cancers 2023 highlights: rare cancers at the forefrontПодробнее

Changing course and improving dismal outcomes in lung cancer: 2022 ESMO FloridaПодробнее

Highlights in Lung Cancer form ESMO 2022Подробнее

Highlights in GI from ESMO 2022Подробнее

Highlights in Lung Cancer from° ESMO 2022Video in PortugueseПодробнее

ESMO 2022: Highlights, commentary and analysisПодробнее

ESMO 2022 highlightsПодробнее

ESMO 2022 highlights in head and neck cancerПодробнее

ESMO highlights: KRAS G12C inhibitorsПодробнее

ESMO 2022: Highlights from the Presidential SymposiumПодробнее

Clincal trial highlights in breast cancer at ESMO 2022Подробнее

Highlights in lung cancer at ESMO 2022Подробнее

Highlights in glioblastoma at ESMO 2022Подробнее